MedicineWatch US
Class II Recall

ASTRAZENECA PHARMACEUTICALS

Product
Fasenra (benralizumab) Injection, 30 mg/mL, one single-dose pre-filled syringe, Rx only, Manufactured by: AstraZeneca AB, Sweden, Distributed by: AstraZeneca Pharmaceuticals LP, Wilmington, DE 19850. NDC 0310-1730-30
Reason
Lack of Assurance of Sterility:
Classification
Class II
Status
Ongoing
Lot
Lot YJ0152, Expiry: 01/31/2028.
Date
Disclaimer: This tool indexes published US FDA drug-enforcement recall records from all countries, limited to the latest five years. A company or product not appearing here is not proof that it is compliant, approved, safe, or free of FDA action.